
The Opioid Crisis, CEO Pay, and Shareholder Activism
Cold Call
Should the CEO's Pay Be Reduced?
The central issue on the face of it is as you read in the title of the case. A medicine paid along with the two other big distributors from the critical distributors. There are three of them who cover vast majority of the market even though it's a fairly distributed marketplace. The charge was that because of lax policies and controls, they had facilitated illegal distribution of opioids.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.